Abstract
Liquid crystalline systems of monoolein/water could be a promising approach for the delivery of celecoxib (CXB) to the skin because these systems can sustain drug release, improve drug penetration into the skin layers and minimize side effects. This study evaluated the potential of these systems for the delivery of CXB into the skin based on in vitro drug release and skin permeation studies. The amount of CXB that permeated into and/or was retained in the skin was assayed using an HPLC method. Polarizing light microscopy studies showed that liquid crystalline systems of monoolein/water were formed in the presence of CXB, without any changes in the mesophases. The liquid crystalline systems decreased drug release when compared to control solution. Drug release was independent of the initial water content of the systems and CXB was released from cubic phase systems, irrespective of the initial water content. The systems released the CXB following zero-order release kinetics. In vitro drug permeation studies showed that cubic phase systems allowed drug permeation and retention in the skin layers. Cubic phase systems of monoolein/water may be promising vehicles for the delivery of CXB in/through the skin because it improved CXB skin permeation compared with the control solution.
Similar content being viewed by others
REFERENCES
Cid YP, Pedrazzi V, Sousa VP, Pierre MBR. In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer. AAPS PharmSciTech. 2012;13:101–11.
Ventura CA, Tommazini S, Falcone A, Gianonne I, Paolino D, Sdrafkakis V, et al. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin. Int J Pharm. 2006;314:37–45.
Subramanian N, Ghosal SK, Moulik SP. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Dev Ind Pharm. 2005;31:405–16.
Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm. 2008;346:124–32.
Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol. 2008;6:1–11.
Soliman SM, Malak NSA, El-Gazayerly ON, Rehim AAA. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: in vitro permeation, anti-inflammatory activity and skin irritation tests. Drug Discov Ther. 2010;4:459–71.
Sharma PK, Bajpai M. Enhancement of solubility and stability of Celecoxib using microemulsion based topical formulation. J Pharm Res. 2011;4:2216–20.
Quiñones OG, Mata Dos Santos HA, Kibwila DM, Leitão A, Dos Santos Pyrrho A, Pádua MD et al. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. Drug Dev Ind Pharm 2013. doi:10.3109/03639045.2013.809731.
Bender J, Jarvoll P, Nydén M, Engstron S. Structure and dynamics of a sponge phase in the methyl σ-aminolevulinate/monoolein/water/propylene glycol system. J Colloid Interface Sci. 2008;317:577–84.
Yariv D, Efrat R, Libster D, Aserin A, Garti N. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems. Colloids Surf B: Biointerfaces. 2010;78:185–92.
Praça FS, Bentley MV, Lara MG, Pierre MB. Celecoxib determination in different layers of skin by a newly developed and validated HPLC-UV. Biomed Chromatogr. 2011;25:1237–44.
Lopes LB, Ferreira DA, de Paula D, Garcia MTJ, Thomazini JA, Fantini MCA, et al. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporine A. Pharm Res. 2006;23:1332–42.
Yener G, Gonullu U, Uner M, Degim T, Araman A. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin. Pharmazie. 2003;58:330–3.
Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev. 2001;47:229–50.
Engström S, Engström L. Phase behaviour of the lidocaine-monoolein-water system. Int J Pharm. 1992;79:113–22.
Kumar MK, Shah MH, Ketkar A, Mahadik KR, Paradkar A. Effect of drug solubility and different excipients on floating behavior and release from glyceryl monooleate matrices. Int J Pharm. 2004;272:151–60.
Steluti R, De Rosa FS, Collett J, Tedesco AC, Bentley MVLB. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Eur J Pharm Biopharm. 2005;60:439–44.
Caboi F, Amico GS, Pitzalis P, Monduzzi M, Nylander T, Larson K. Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system. I. Phase behavior. Chem Phys Lipids. 2001;109:47–62.
Boyd BJ, Whittaker DV, Khoo SM, Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm. 2006;309:218–26.
Chang CM, Bodmeier R. Effect of dissolution media and additives on the drug release from cubic phase delivery systems. J Control Release. 1997;46:215–22.
Shah MH, Paradkar A. Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. Eur J Pharm Biopharm. 2007;67:166–74.
Ganen-Quintanar A, Quintanar-Guerreiro D, Buri P. Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm. 2000;26:809–20.
Guo C, Wang J, Cao F, Lee RJ, Zhai G. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15:1032–40.
Fong C, Le T, Drummond CJ. Lyotropic liquid crystal engineering-ordered nanostructured small molecule amphiphile self-assembly materials by design. Chem Soc Rev. 2012;41:1297–322.
Sallam A, Khalil E, Ibrahim H, Freij I. Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate. Eur J Pharm Biopharm. 2002;53:343–52.
Costa-Balogh FOC, Sparr E, Souza JJS, Paes AC. Drug release from lipid liquid crystalline phases: relation with phase behavior. Drug Dev Ind Pharm. 2010;36:470–81.
Simonetti LDD, Gelfuso GM, Barbosa JCR, Lopez RFV. Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. Eur J Pharm Biopharm. 2009;73:90–4.
Lopes LB, Speretta FFF, Bentley MVLB. Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems. Eur J Pharm Sci. 2007;32:209–15.
Carr MG, Corish J, Corrigan OI. Drug delivery from a liquid crystalline base across visking and human stratum corneum. Int J Pharm. 1997;157:35–42.
Clogston J, Rathman J, Tomasko D, Walker H, Caffrey M. Phase behavior of a monoacylglycerol (Myverol 18-99K)/water system. Chem Phys Lipids. 2000;107:191–220.
Burrows R, Collett JH, Attwood D. The release of drugs from monoglyceride-water liquid crystalline phases. Int J Pharm. 1994;111:283–93.
Rigter PL, Peppas NA. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5:37–42.
Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
Chang CM, Bodmeier R. Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase. Int J Pharm. 1998;173:51–60.
Phan S, Fong WK, Kirby N, Hanley T, Boyd BJ. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm. 2011;421:176–82.
Norling T, Lading P, Engströn S, Larsson K, Krog N, Nissen SS. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J Clin Periodontol. 1992;19:687–92.
Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery systems. I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate. Eur J Pharm Sci. 1998;6:231–9.
Dantona P, Parker Jr WO, Zanirato MC, Esposito E, Nastruzzi C. Rheologic and NMR characterization of monoglyceride-based formulations. J Biomed Mater Res. 2000;52:40–52.
Alfons K, Engström S. Drug compatibility with the sponge phases formed in monoolein, water and propyleneglycol or poly (ethylene glycol). J Pharm Sci. 1998;87:1527–30.
Chang CM, Bodmeier R. Swelling of and drug release from monoglyceride-based drug delivery systems. J Pharm Sci. 1997;86:747–52.
Geraghty PB, Attwood D, Collett JH, Dandiker Y. The in vitro release of some antimuscarinic drugs from monoolein/water lyotropic liquid crystalline gels. Pharm Res. 1996;13:1265–71.
Rizwan SB, Hanley T, Boyd BJ, Rades T, Hook S. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterization, swelling and release kinetics. J Pharm Sci. 2009;98:4191–204.
Lee J, Kellaway IW. In vitro peptide release from liquid crystalline buccal delivery systems. Int J Pharm. 2000;195:29–33.
Lara MG, Bentley MV, Collett JH. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm. 2005;293:241–50.
Bertram U, Bodmeier R. Parameters affecting the drug release from in situ gelling nasal inserts. Eur J Pharm Biopharm. 2006;63:310–9.
Allababidi S, Shah JC. Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation. J Pharm Sci. 1998;87:738–44.
ACKNOWLEDGMENTS
The authors thank Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) e Universidade de São Paulo (USP), Brazil for supporting this study.
Conflict of interest
The authors report no declarations of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Estracanholli, É.A., Praça, F.S.G., Cintra, A.B. et al. Liquid Crystalline Systems for Transdermal Delivery of Celecoxib: In Vitro Drug Release and Skin Permeation Studies. AAPS PharmSciTech 15, 1468–1475 (2014). https://doi.org/10.1208/s12249-014-0171-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-014-0171-2